Health and Fitness Health and Fitness
Thu, September 9, 2010
[ Thu, Sep 09th 2010 ] - Market Wire
Cubist Pharmaceuticals Prepares for Continued Growth
[ Thu, Sep 09th 2010 ] - Market Wire
Emergent BioSolutions Announces Early Termination .. od for Its Acquisition of Trubion Pharmaceuticals
[ Thu, Sep 09th 2010 ] - Market Wire
Unigene to Present at the Rodman & Renshaw 12th Annual Healthcare Conference
[ Thu, Sep 09th 2010 ] - Market Wire
Santarus Licenses Novel Type 2 Diabetes Drug CYCLOSET
[ Thu, Sep 09th 2010 ] - Market Wire
Obagi Medical Products to Present at Three Investor Conferences in September
[ Thu, Sep 09th 2010 ] - Market Wire
Helicos BioSciences Files Patent Infringement Lawsuit Against Pacific Biosciences
[ Thu, Sep 09th 2010 ] - Market Wire
Media Advisory - Oncolytics Biotech(R) Inc. to Pr .. an &; Renshaw Annual Global Investment Conference
[ Thu, Sep 09th 2010 ] - Market Wire
LabCorp is Scheduled to Present at the Bank of America Merrill Lynch Investment Conference
[ Thu, Sep 09th 2010 ] - Market Wire
Santarus to Present at September Investment Conferences
[ Thu, Sep 09th 2010 ] - Market Wire
Gallup and Healthways Release August 2010 U.S. Well-Being Report
[ Thu, Sep 09th 2010 ] - Market Wire
Schiff Nutrition International, Inc. Announces Timing of Fiscal 2011 First Quarter Results
[ Thu, Sep 09th 2010 ] - Market Wire
Schiff Nutrition International, Inc. to Present a .. ing's 8th Best Ideas Conference on September 16th
[ Thu, Sep 09th 2010 ] - Market Wire
Salix Pharmaceuticals to Present at Stifel Nicolaus Conference
[ Thu, Sep 09th 2010 ] - Market Wire
CombinatoRx Changes Company Name to Zalicus Inc.
[ Thu, Sep 09th 2010 ] - Market Wire
AngioDynamics to Participate At Upcoming Investor Conferences
Wed, September 8, 2010
[ Wed, Sep 08th 2010 ] - Market Wire
Chemed Corporation to Present at CL Kinga?s 8th Annual Best Ideas Conference
[ Wed, Sep 08th 2010 ] - Market Wire
Robert Butts holdings in Adherex Technologies Inc. (TSX: AHX)
[ Wed, Sep 08th 2010 ] - Market Wire
Zacks Releases Four Powerful ''Buy'' Stocks: The .. Insurance Group, Alliance Holdings GP, LP and G-
[ Wed, Sep 08th 2010 ] - Market Wire
Faruqi & Faruqi, LLP Announces Investigation Rela .. to the Acquisition of ZymoGenetics, Inc. a" ZGEN
[ Wed, Sep 08th 2010 ] - Market Wire
AtriCure Announces September Investor Conference Schedule
[ Wed, Sep 08th 2010 ] - Market Wire
Emergent BioSolutions Announces Commencement of P .. Monoclonal Antibody to Treat Inhalational Anthrax
[ Wed, Sep 08th 2010 ] - Market Wire
Bristol-Myers Squibb to Acquire ZymoGenetics
[ Wed, Sep 08th 2010 ] - Market Wire
Law Office of Jonathan M. Stein, P.L. Investigate .. Fiduciary Duty by the Board of ZymoGenetics, Inc.
[ Wed, Sep 08th 2010 ] - Market Wire
IntegraMed® to Present on Singular Researcha?s " .. lling Values" Webcast Wed., Sept. 15th at Noon ET
[ Wed, Sep 08th 2010 ] - Market Wire
CIPHER PHARMACEUTICALS TO PRESENT AT RODMAN &; RENSHAW ANNUAL GLOBAL INVESTMENT CONFERENCE
[ Wed, Sep 08th 2010 ] - Market Wire
The Briscoe Law Firm Investigates ZymoGenetics In .. quisition of ZymoGenetics by Bristol-Myers Squibb
[ Wed, Sep 08th 2010 ] - Market Wire
Ryan & Maniskas, LLP Announces Investigation of ZymoGenetics, Inc.
[ Wed, Sep 08th 2010 ] - Market Wire
Large Insider Trades Found in Momenta Pharmaceuti .. rinthian Colleges, OmniVision, & F5 Networks; Rep
[ Wed, Sep 08th 2010 ] - Market Wire
YM BioSciences announces positive results from CY .. se I study published in British Journal of Cancer
[ Wed, Sep 08th 2010 ] - Market Wire
Inspire Announces Webcast of Presentation at Stifel Nicolaus Healthcare Conference

Inspire Announces Webcast of Presentation at Stifel Nicolaus Healthcare Conference


Published on 2010-09-08 06:52:16 - Market Wire
  Print publication without navigation


DURHAM, N.C.--([ BUSINESS WIRE ])--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today that Adrian Adams, President and CEO, will present at the Stifel Nicolaus 2010 Healthcare Conference on Wednesday, September 15, 2010 at 2:40 pm ET in Boston, MA.

The webcast of the presentation will be available on Inspirea™s web site at [ www.inspirepharm.com ]. An archived version of the webcast presentation will also be available through this link for a limited time following the conference.

About Inspire

Inspire is a biopharmaceutical company focused on researching, developing and commercializing prescription pharmaceutical products for ophthalmic and pulmonary diseases. Inspirea™s goal is to build and commercialize a sustainable portfolio of innovative new products based on its technical, scientific and commercial expertise. Inspirea™s clinical pipeline includes denufosol tetrasodium for cystic fibrosis in Phase 3 development and AZASITE®(azithromycin ophthalmic solution) 1% for blepharitis in Phase 2 development. Inspire receives revenues related to the promotion of AZASITE for bacterial conjunctivitis, the co-promotion of ELESTAT® (epinastine HCl ophthalmic solution) 0.05% for allergic conjunctivitis and royalties based on net sales of RESTASIS® (cyclosporine ophthalmic emulsion) 0.05% for dry eye. For more information, visit [ www.inspirepharm.com ].

Contributing Sources